Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies-Reference-Cited by-同舟云学术

Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies

Published:2024-05 Issue:5 Volume:5 Page:401-413.e4
ISSN:2666-6340
Container-title:Med
language:en
Short-container-title:Med

Author:

He Qingwen,An Yaling,Zhou Xuemei,Xie Haitang,Tao Lifeng,Li Dedong,Zheng Anqi,Li Linjie,Xu Zepeng,Yu Shufan,Wang Ruyue,Hu Hua,Liu Kefang,Wang Qihui,Dai Lianpan,Xu Kun,Gao George F.^ORCID

Publisher

Elsevier BV

Reference42 articles.

1. What to know about EG.5, the latest SARS-CoV-2 "variant of interest";Abbasi;JAMA,2023

2. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo;Uraki;Cell Rep.,2023

3. Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3;Zhang;Lancet Infect. Dis.,2023

4. Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6;Wang;Lancet Infect. Dis.,2023

5. First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023;Rasmussen;Euro Surveill.,2023

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective RBD-dimer vaccines against SARS-CoV-2 and its variants produced in glycoengineered Pichia pastoris;PLOS Pathogens;2024-08-30

2. Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants;Cell Reports;2024-08

3. Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion;2024-05-21

4. Enhanced potency of an IgM-like nanobody targeting conserved epitope in SARS-CoV-2 spike N-terminal domain;Signal Transduction and Targeted Therapy;2024-05-13